#liver decompensation

Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.

Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.

Indicators of liver health improved at the same rate among those with cirrhosis who were cured of hep C regardless of their HIV status.

Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

Those coinfected with hepatitis C and HIV who have advanced fibrosis should receive hep C therapy, because of the risk of developing liver dec...

Even a partial response to hepatitis C virus (HCV) therapy confers significant health benefits to people coinfected with both HIV and HCV, tho...